Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedMay 24, 2025
DataAggregated Company Financials
Companies63
  • 7D-5.0%
  • 3M-11.8%
  • 1Y-58.2%
  • YTD-30.8%

Over the last 7 days, the Pharma industry has dropped 6.3%, driven by Trulieve Cannabis declining 7.2%. In contrast, Canopy Growth has gained 9.6%. However, the industry is down 58% over the past year. Earnings are forecast to grow by 61% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 May 2025CA$23.8bCA$11.8b-CA$2,386,824,912.0317.8x-10x2x
Mon, 21 Apr 2025CA$9.7bCA$12.0b-CA$2,565,498,718.6519.1x-3.8x0.8x
Wed, 19 Mar 2025CA$10.7bCA$12.3b-CA$2,640,199,995.4019.1x-4.1x0.9x
Fri, 14 Feb 2025CA$12.4bCA$12.1b-CA$2,212,969,547.0023.8x-5.6x1x
Sun, 12 Jan 2025CA$12.4bCA$12.2b-CA$2,417,209,526.7728.7x-5.1x1x
Tue, 10 Dec 2024CA$13.6bCA$12.0b-CA$2,581,746,931.1223x-5.3x1.1x
Thu, 07 Nov 2024CA$19.1bCA$11.9b-CA$2,771,044,784.6618x-6.9x1.6x
Sat, 05 Oct 2024CA$18.6bCA$11.6b-CA$2,680,134,100.3027.4x-6.9x1.6x
Mon, 02 Sep 2024CA$17.1bCA$11.6b-CA$2,690,218,404.9420.2x-6.4x1.5x
Wed, 31 Jul 2024CA$20.1bCA$11.8b-CA$3,212,184,320.3420x-6.2x1.7x
Fri, 28 Jun 2024CA$20.4bCA$11.8b-CA$3,239,151,617.4318.8x-6.3x1.7x
Sun, 26 May 2024CA$21.8bCA$11.9b-CA$3,490,501,699.0812.8x-6.2x1.8x
Tue, 23 Apr 2024CA$23.2bCA$12.0b-CA$3,476,028,729.958.2x-6.7x1.9x
Thu, 21 Mar 2024CA$22.6bCA$11.8b-CA$3,477,097,457.189.5x-6.5x1.9x
Sat, 17 Feb 2024CA$22.3bCA$12.0b-CA$4,643,332,391.6110.4x-4.8x1.9x
Mon, 15 Jan 2024CA$20.3bCA$12.3b-CA$6,744,251,485.009.3x-3x1.7x
Wed, 13 Dec 2023CA$17.3bCA$12.4b-CA$6,782,848,879.008.2x-2.6x1.4x
Fri, 10 Nov 2023CA$16.9bCA$12.5b-CA$7,314,992,422.0010.3x-2.3x1.4x
Sun, 08 Oct 2023CA$18.6bCA$12.4b-CA$7,334,632,248.0015x-2.5x1.5x
Tue, 05 Sep 2023CA$18.0bCA$13.0b-CA$7,911,625,052.0013.3x-2.3x1.4x
Thu, 03 Aug 2023CA$15.2bCA$13.3b-CA$9,743,091,053.0012.1x-1.6x1.1x
Sat, 01 Jul 2023CA$14.8bCA$13.2b-CA$9,514,993,365.0011.4x-1.6x1.1x
Mon, 29 May 2023CA$14.9bCA$13.4b-CA$10,471,665,836.0010.2x-1.4x1.1x
Wed, 26 Apr 2023CA$14.9bCA$13.5b-CA$9,997,376,351.0010.8x-1.5x1.1x
Fri, 24 Mar 2023CA$17.2bCA$13.8b-CA$10,095,082,425.009.1x-1.7x1.2x
Sun, 19 Feb 2023CA$20.4bCA$13.6b-CA$10,307,884,782.0010.5x-2x1.5x
Tue, 17 Jan 2023CA$20.9bCA$13.5b-CA$10,099,014,878.0013.4x-2.1x1.5x
Thu, 15 Dec 2022CA$23.4bCA$13.6b-CA$10,200,923,205.0015.9x-2.3x1.7x
Sat, 12 Nov 2022CA$29.7bCA$13.3b-CA$9,951,468,821.0013.6x-3x2.2x
Mon, 10 Oct 2022CA$30.4bCA$13.4b-CA$9,400,489,803.0012.5x-3.2x2.3x
Wed, 07 Sep 2022CA$30.9bCA$13.1b-CA$8,794,047,387.0015x-3.5x2.4x
Fri, 05 Aug 2022CA$27.9bCA$12.3b-CA$5,845,497,689.0013.4x-4.8x2.3x
Sun, 03 Jul 2022CA$25.0bCA$12.2b-CA$5,766,408,417.0011.5x-4.3x2x
Tue, 31 May 2022CA$31.2bCA$12.1b-CA$5,493,611,920.009.7x-5.7x2.6x
Price to Earnings Ratio

-5.7x


Total Market Cap: CA$31.2bTotal Earnings: -CA$5,493,611,920.00Total Revenue: CA$12.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -4x202320242025
Current Industry PE
  • Investors are optimistic on the Canadian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 1.6x is lower than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market-0.17%
Healthcare-3.47%
Pharma-4.96%
Pharma-4.96%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WEED Canopy GrowthCA$2.519.6%
+CA$34.8m		-80.0%PS1.4x
CURA Curaleaf HoldingsCA$1.193.5%
+CA$30.3m		-81.3%PS0.5x
NGEN NervGen PharmaCA$5.109.0%
+CA$29.8m		147.6%PB260.6x
ACB Aurora CannabisCA$7.545.3%
+CA$20.9m		-17.0%PE23.3x
ZYUS ZYUS Life SciencesCA$0.7421.3%
+CA$9.9m		-27.5%PS117.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

LABS

CA$0.075

MediPharm Labs

7D

-16.7%

1Y

-6.3%

GTII

CA$7.43

Green Thumb Industries

7D

-5.9%

1Y

-51.8%

ACB

CA$7.54

Aurora Cannabis

7D

5.3%

1Y

-17.0%

After Leaping 29% Aurora Cannabis Inc. (TSE:ACB) Shares Are Not Flying Under The Radar

May 23
After Leaping 29% Aurora Cannabis Inc. (TSE:ACB) Shares Are Not Flying Under The Radar

ZYUS

CA$0.74

ZYUS Life Sciences

7D

21.3%

1Y

-27.5%

WEED

CA$2.51

Canopy Growth

7D

9.6%

1Y

-80.0%

Investors Appear Satisfied With Canopy Growth Corporation's (TSE:WEED) Prospects As Shares Rocket 40%

May 18
Investors Appear Satisfied With Canopy Growth Corporation's (TSE:WEED) Prospects As Shares Rocket 40%

PLTH

CA$0.33

Planet 13 Holdings

7D

-5.7%

1Y

-58.8%

NGEN

CA$5.10

NervGen Pharma

7D

9.0%

1Y

147.6%

CRON

CA$2.79

Cronos Group

7D

-6.4%

1Y

-23.1%

XLY

CA$0.085

Auxly Cannabis Group

7D

-5.6%

1Y

88.9%

TRUL

CA$5.76

Trulieve Cannabis

7D

-7.2%

1Y

-59.5%

VRNO

CA$0.95

Verano Holdings

7D

2.2%

1Y

-82.8%

MTLC

CA$0.39

MTL Cannabis

7D

21.9%

1Y

41.8%

Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 27% Bounce

May 14
Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 27% Bounce

TSND

CA$0.55

TerrAscend

7D

5.8%

1Y

-74.4%

CURA

CA$1.19

Curaleaf Holdings

7D

3.5%

1Y

-81.3%

CL

CA$0.91

Cresco Labs

7D

-5.2%

1Y

-65.5%

Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

May 01
Cresco Labs Inc.'s (CSE:CL) Shares Climb 31% But Its Business Is Yet to Catch Up

HITI

CA$3.15

High Tide

7D

-5.4%

1Y

-0.5%

author-image

Expanding German Medical Cannabis And Cabana Club Will Build Opportunities

Strategic expansion in the German market and leveraging Canadian connections may boost future revenue.